{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:27:46Z","timestamp":1761560866813},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2004,2,24]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background\u2014<\/jats:italic>\n            <\/jats:bold>\n            In diabetic patients in the Evaluation of Platelet IIb\/IIIa Inhibitor for Stenting (EPISTENT) trial, abciximab reduced target vessel revascularization by \u224850% compared with placebo. Whether this is a result of a lower restenosis rate caused by inhibition of intimal hyperplasia remains to be defined.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods and Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            The purpose of this study was to determine whether abciximab at the time of stent implantation would reduce in-stent intimal hyperplasia measured by intravascular ultrasound at 6-month follow-up in type 2 diabetics. Ninety-six diabetic patients (96 lesions) who underwent elective stent implantation for a de novo lesion in a native coronary artery were randomly assigned to receive abciximab or no abciximab. In-stent intimal hyperplasia volume, expressed as percentage of stent volume, did not differ between groups: 41.3\u00b121.0% for those treated with abciximab versus 40.5\u00b118.3% for those treated without abciximab (\n            <jats:italic>P<\/jats:italic>\n            =0.9). There were also no significant differences in angiographic minimal luminal diameter at follow-up (1.74\u00b10.69 versus 1.66\u00b10.63 mm;\n            <jats:italic>P<\/jats:italic>\n            =0.5), late loss (1.03\u00b10.63 versus 1.07\u00b10.58 mm;\n            <jats:italic>P<\/jats:italic>\n            =0.7), restenosis rate (17.8% versus 22.9%;\n            <jats:italic>P<\/jats:italic>\n            =0.5), or cumulative incidence of major adverse cardiac events at 12 months (19.1% versus 20.4%;\n            <jats:italic>P<\/jats:italic>\n            =0.9).\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            Six-month intravascular ultrasound volumetric analysis showed that abciximab, at the time of coronary stent implantation, was not associated with a reduction of in-stent intimal hyperplasia in diabetic patients.\n          <\/jats:p>","DOI":"10.1161\/01.cir.0000116752.12261.d4","type":"journal-article","created":{"date-parts":[[2004,2,3]],"date-time":"2004-02-03T01:23:56Z","timestamp":1075771436000},"page":"861-866","update-policy":"http:\/\/dx.doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":32,"title":["Volumetric Analysis of In-Stent Intimal Hyperplasia in Diabetic Patients Treated With or Without Abciximab"],"prefix":"10.1161","volume":"109","author":[{"given":"A\u0301urea J.","family":"Chaves","sequence":"first","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda G.M.R.","family":"Sousa","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz A.","family":"Mattos","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Abizaid","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Staico","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Feres","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinella","family":"Centemero","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz F.","family":"Tanajura","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Abizaid","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibraim","family":"Pinto","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galo","family":"Maldonado","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Seixas","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Costa","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A\u0302ngela","family":"Paes","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary S.","family":"Mintz","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Eduardo","family":"Sousa","sequence":"additional","affiliation":[{"name":"From Instituto \u201cDante Pazzanese\u201d de Cardiologia, Sa\u0303o Paulo, Brazil; and the Cardiovascular Research Foundation (G.S.M.), New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00467-7"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00286-1"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00574-X"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404073301402"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199706123362401"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)85010-1"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00650-6"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907293410503"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.100.25.2477"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00895-0"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.96.5.1454"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.95.6.1366"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00316-7"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000025585.63486.59"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000054163.42072.d4"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(03)00114-5"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.23.10624"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00417-2"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108872"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.98.11.1085"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.17.3.528"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1612971"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(02)00207-4"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00496-3"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.100.8.799"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00635-X"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90007-8"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.97.19.1912"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000018123.02672.c7"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2606"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.103.10.1403"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.19.2411"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.0000116752.12261.D4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T18:31:09Z","timestamp":1715020269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.0000116752.12261.D4"}},"subtitle":["Results of the Diabetes Abciximab steNT Evaluation (DANTE) Randomized Trial"],"short-title":[],"issued":{"date-parts":[[2004,2,24]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,2,24]]}},"alternative-id":["10.1161\/01.CIR.0000116752.12261.D4"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.0000116752.12261.d4","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,24]]},"assertion":[{"value":"2004-02-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}